Allo-Pure

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAllo-Pure
Drug Alias Nameuric acid lowering agent
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionXanthine dehydrogenase inhibitors
TargetsXanthine dehydrogenase
Therapy Area/IndicationsObesityHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Allopurinol
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesXortx Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXortx Therapeutics
Active IndicationsN/A
Inactive IndicationsObesityHypertension

Other Information

ATC CodeN/A
Related LinksN/A